
Beyond Medical Technologies Provides Update on 2024 Annual Filings
Beyond Medical Technologies Provides Update on 2024 Annual Filings
May 15, 2025
Beyond Medical Technologies Inc.
Vancouver, British Columbia – (Newsfile Corp. – May 15, 2025) – Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is providing an update with respect to the management cease trade order ("MCTO") issued by the British Columbia Securities Commission (the "BCSC") on May 1, 2025, and as previously announced by the Company.
The MCTO was issued by the BCSC in connection with the delay by the Company in filing its audited annual financial statements and accompanying management's discussion and analysis and related CEO and CFO certificates for the financial year ended December 31, 2024 (collectively, the "Annual Filings").
The Company is providing this status update in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). The audit is nearly complete, and the Company expects to file the Annual Filings within the next few days and no later than June 30, 2025.
The Company will issue a news release once the Annual Filings have been filed. Until the Company files the Annual Filings, it will comply with the alternative information guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases.
The Company confirms as of the date of this news release that there has been no material change in the information contained in the Company's news release issued May 2, 2025, and there is no other material information concerning the affairs of the Company that has not been generally disclosed.
About Beyond Medical Technologies Inc.
Beyond Medical Technologies Inc. is a healthcare technology company integrating blockchain infrastructure to enhance patient outcomes and operational efficiency across the medical ecosystem.
On behalf of the Board of Directors
Daniel Liu, Chief Executive Officer
Email: daniel@beyond-md.co
https://beyond-md.co/
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.